Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HSK44459 in atopic dermatitis
NCT06996912Phase 2Active, not recruiting
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Start
- May 2025
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HSK44459 in atopic dermatitis (AD), sponsored by Haisco Pharmaceutical Group Co., Ltd.. Started May 2025; status: active, not recruiting.
02
Drugs
HSK44459
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT06996912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06996912.